Cancer Cell International,
Journal Year:
2022,
Volume and Issue:
22(1)
Published: Oct. 18, 2022
Abstract
Exosomes
are
naturally
occurring
nanosized
particles
that
aid
intercellular
communication
by
transmitting
biological
information
between
cells.
have
therapeutic
efficacy
can
transfer
their
contents
cells
as
natural
carriers.
In
addition,
the
exosomal
delivered
to
recipient
pathological
significantly
inhibit
cancer
progression.
However,
exosome-based
tumor
treatments
inadequately
precise
or
successful,
and
various
challenges
should
be
adequately
overcome.
Here,
we
discuss
significant
exosomes
face
drug
carriers
used
for
targets
strategies
overcoming
these
in
order
promote
this
new
incoming
carrier
further
improve
future
clinical
outcomes.
We
also
present
techniques
challenges.
Molecular Cancer,
Journal Year:
2019,
Volume and Issue:
18(1)
Published: March 13, 2019
Metastasis
is
the
main
cause
of
lung
cancer
mortality.
Bone
marrow-derived
mesenchymal
stem
cells
(BMSCs)
are
a
component
microenvironment
and
contribute
to
progression.
Intratumoral
hypoxia
affects
both
stromal
cells.
Exosomes
recognized
as
mediators
intercellular
communication.
Here,
we
aim
further
elucidate
communication
between
BMSC-derived
exosomes
in
hypoxic
niche.
Exosomal
miRNA
profiling
was
performed
using
microRNA
array.
Lung
an
vivo
mouse
syngeneic
tumor
model
were
used
evaluate
effects
select
exosomal
microRNAs.
Hypoxic
plasma
miRNAs
assessed
for
their
capacity
discriminate
patients
non-cancerous
controls
with
or
without
metastasis.
We
demonstrate
that
derived
from
BMSCs
taken
by
neighboring
promote
cell
invasion
EMT.
Exosome-mediated
transfer
microRNAs,
including
miR-193a-3p,
miR-210-3p
miR-5100,
epithelial
activates
STAT3
signaling
increases
expression
related
molecules.
The
diagnostic
accuracy
individual
showed
miR-193a-3p
can
controls.
A
panel
these
three
microRNAs
better
metastasis
than
microRNA.
could
activating
signalling-induced
These
may
be
promising
noninvasive
biomarkers
Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: Feb. 4, 2020
Spinal
cord
injury
(SCI)
can
lead
to
severe
motor
and
sensory
dysfunction
with
high
disability
mortality.
In
recent
years,
mesenchymal
stem
cell
(MSC)-secreted
nano-sized
exosomes
have
shown
great
potential
for
promoting
functional
behavioral
recovery
following
SCI.
However,
MSCs
are
usually
exposed
normoxia
in
vitro,
which
differs
greatly
from
the
hypoxic
micro-environment
vivo.
Thus,
main
purpose
of
this
study
was
determine
whether
derived
under
hypoxia
(HExos)
exhibit
greater
effects
on
than
those
(Exos)
SCI
mice
seek
underlying
mechanism.Electron
microscope,
nanoparticle
tracking
analysis
(NTA),
western
blot
were
applied
characterize
differences
between
Exos
HExos
group.
A
model
vivo
a
series
vitro
experiments
performed
compare
therapeutic
two
groups.
Next,
miRNA
microarray
rescue
conducted
verify
role
exosomal
Western
blot,
luciferase
activity,
RNA-ChIP
used
investigate
mechanisms.Our
results
indicate
that
promote
by
shifting
microglial
polarization
M1
M2
phenotype
vitro.
array
showed
miR-216a-5p
be
most
enriched
potentially
involved
HExos-mediated
polarization.
TLR4
identified
as
target
downstream
gene
miR-216a-5p/TLR4
axis
confirmed
gain-
loss-of-function
experiments.
Finally,
we
found
TLR4/NF-κB/PI3K/AKT
signaling
cascades
may
modulation
miR-216a-5p.Hypoxia
preconditioning
represents
promising
effective
approach
optimize
actions
MSC-derived
combination
miRNAs
present
minimally
invasive
method
treating
Cells,
Journal Year:
2019,
Volume and Issue:
8(5), P. 467 - 467
Published: May 16, 2019
Mesenchymal
stem
cell
(MSC)-sourced
secretome,
defined
as
the
set
of
MSC-derived
bioactive
factors
(soluble
proteins,
nucleic
acids,
lipids
and
extracellular
vesicles),
showed
therapeutic
effects
similar
to
those
observed
after
transplantation
MSCs.
secretome
may
bypass
many
side
MSC-based
therapy,
including
unwanted
differentiation
engrafted
In
contrast
MSCs
which
had
be
expanded
in
culture
reach
optimal
number
for
transplantation,
MSC-sourced
is
immediately
available
treatment
acute
conditions,
fulminant
hepatitis,
cerebral
ischemia
myocardial
infarction.
Additionally,
could
massively
produced
from
commercially
lines
avoiding
invasive
collection
procedure.
this
review
article
we
emphasized
molecular
cellular
mechanisms
that
were
responsible
beneficial
secretomes
degenerative
inflammatory
diseases
hepatobiliary,
respiratory,
musculoskeletal,
gastrointestinal,
cardiovascular
nervous
system.
Results
obtained
a
large
studies
suggested
administration
represents
new,
cell-free
approach
attenuation
diseases.
Therapeutic
relied
on
their
capacity
deliver
genetic
material,
growth
immunomodulatory
target
cells
enabling
activation
anti-apoptotic
pro-survival
pathways
resulted
tissue
repair
regeneration.
Theranostics,
Journal Year:
2019,
Volume and Issue:
9(4), P. 1015 - 1028
Published: Jan. 1, 2019
Exosomes
have
great
potential
to
be
drug
delivery
vehicles
due
their
natural
material
transportation
properties,
intrinsic
long-term
circulatory
capability,
and
excellent
biocompatibility,
which
are
suitable
for
delivering
a
variety
of
chemicals,
proteins,
nucleic
acids,
gene
therapeutic
agents.However,
an
effective
method
loading
specific
protein
agents
into
exosomes
absorption
by
target
cells
is
still
lacking.The
application
exosome
limited.In
this
review,
we
discussed
the
methods
treating
molecules
(proteins,
acids
small
chemicals)
exosomes,
design
strategies
cell
tissue
targeting,
factors
formation.This
review
can
used
as
reference
further
research
well
development
exosomes.
Advanced Functional Materials,
Journal Year:
2020,
Volume and Issue:
30(37)
Published: March 11, 2020
The
therapeutic
benefits
of
mesenchymal
stromal
cell
(MSC)
transplantation
have
been
attributed
to
their
secreted
factors,
including
extracellular
vesicles
(EVs)
and
soluble
factors.
potential
employing
the
MSC
secretome
as
an
alternative
acellular
approach
therapy
is
being
investigated
in
various
tissue
injury
indications,
but
EVs
administered
via
bolus
injections
are
rapidly
sequestered
cleared.
However,
biomaterials
offer
delivery
platforms
enhance
EV
retention
rates
healing
efficacy.
In
this
review,
we
highlight
mechanisms
underpinning
effects
MSC-EVs
factors
effectors
immunomodulation
regeneration,
conferred
primarily
nucleic
acid
protein
contents.
We
discuss
how
manipulating
culture
microenvironment
or
genetic
modification
MSCs
can
further
augment
potency
secretions.
most
recent
advances
development
EV-functionalized
that
mediate
enhanced
angiogenesis
survival,
while
attenuating
inflammation
fibrosis,
presented.
Finally,
some
technical
challenges
be
considered
for
clinical
translation
carrying
MSC-secreted
bioactive
cargo
discussed.
Cardiovascular Research,
Journal Year:
2019,
Volume and Issue:
116(2), P. 353 - 367
Published: May 16, 2019
Abstract
Aims
Naturally
secreted
nanovesicles,
known
as
exosomes,
play
important
roles
in
stem
cell-mediated
cardioprotection.
We
have
previously
demonstrated
that
atorvastatin
(ATV)
pretreatment
improved
the
cardioprotective
effects
of
mesenchymal
cells
(MSCs)
a
rat
model
acute
myocardial
infarction
(AMI).
The
aim
this
study
was
to
investigate
if
exosomes
derived
from
ATV-pretreated
MSCs
exhibit
more
potent
function
AMI
and
so
explore
underlying
mechanisms.
Methods
results
Exosomes
were
isolated
control
(MSC-Exo)
(MSCATV-Exo)
then
delivered
endothelial
cardiomyocytes
vitro
under
hypoxia
serum
deprivation
(H/SD)
condition
or
vivo
an
acutely
infarcted
Sprague-Dawley
heart.
Regulatory
genes
pathways
activated
by
ATV
explored
using
genomics
approaches
functional
studies.
In
vitro,
MSCATV-Exo
accelerated
migration,
tube-like
structure
formation,
increased
survival
but
not
cardiomyocytes,
whereas
MSCATV-Exo-treated
prevented
H/SD-induced
apoptosis.
model,
resulted
recovery
cardiac
function,
further
reduction
infarct
size
reduced
cardiomyocyte
apoptosis
compared
MSC-Exo.
addition,
promoted
angiogenesis
inhibited
elevation
IL-6
TNF-α
peri-infarct
region.
Mechanistically,
we
identified
lncRNA
H19
mediator
role
regulating
expression
miR-675
activation
proangiogenic
factor
VEGF
intercellular
adhesion
molecule-1.
Consistently,
abrogated
when
depleted
mimicked
overexpression
H19.
Conclusion
obtained
significantly
enhanced
therapeutic
efficacy
for
treatment
possibly
through
promoting
cell
function.
LncRNA
mediates,
at
least
partially,
angiogenesis.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2019,
Volume and Issue:
38(1)
Published: Feb. 8, 2019
To
investigate
the
lung
cancer-promoting
mechanism
of
mesenchymal
stem
cell-secreted
extracellular
vesicles
(MSC-EV).EV
were
isolated
from
culture
media
human
bone
marrow-derived
MSCs
that
pre-challenged
with
or
without
hypoxia
(referred
to
as
H-EV
and
N-EV,
respectively).
After
treatment
N-EV
H-EV,
A549
H23
cell
proliferation,
apoptosis,
trans-well
invasion
epithelial-to-mesenchymal
transition
(EMT)
examined.
Polarization
primary
monocytes-derived
macrophages
induction
analyzed
by
flow
cytometry
ELISA.
PTEN,
PDCD4
RECK
gene
was
overexpressed
in
cells,
while
miR-21-5p
knocked
down
MSCs,
cancer
cells
monocytes
inhibitor
transfection.
Protein
level
PDCD4,
RECK,
AKT
STAT3
well
phosphorylation
protein
assayed
western
blot.
Tumorigenicity
MSC-EV
co-injection
on
immunocompromised
mice.
The
xenograft
tumor
examined
for
angiogenesis,
apoptosis
intra-tumoral
M1/M2
macrophage
polarization.Comparing
significantly
increased
survival,
invasiveness
EMT
M2
polarization.
MiR-21-5p
abrogated
polarizing
effects
treatment.
downregulated
expression
largely
through
miR-21-5p.
Overexpressing
reduced
miR-21-5p-mediated
anti-apoptotic
pro-metastatic
effect
overexpressing
PTEN
polarization
after
presence
H-EV.
growth,
angiogenesis
vivo
partially
miR-21-5p.Increased
delivery
pre-challenge
can
promote
development
reducing
promoting
Cells,
Journal Year:
2020,
Volume and Issue:
9(4), P. 991 - 991
Published: April 16, 2020
Mesenchymal
stem
cells
(MSCs)
are
being
extensively
investigated
for
their
potential
in
tissue
engineering
and
regenerative
medicine.
However,
recent
evidence
suggests
that
the
beneficial
effects
of
MSCs
may
be
manifest
by
released
extracellular
vesicles
(EVs);
typically
not
requiring
administration
MSCs.
This
evidence,
predominantly
from
pre-clinical
vitro
vivo
studies,
MSC-EVs
exhibit
substantial
therapeutic
properties
many
pathophysiological
conditions,
potentially
restoring
an
extensive
range
damaged
or
diseased
tissues
organs.
These
benefits
MSC
EVs
apparently
found,
regardless
anatomical
body
fluid
origin
(and
include
e.g.,
bone
marrow,
adipose
tissue,
umbilical
cord,
urine,
etc).
Furthermore,
early
indications
suggest
favourable
could
further
enhanced
modifying
way
which
donor
cultured
(for
example,
hypoxic
compared
to
normoxic
3D
2D
culture
formats)
and/or
if
subsequently
bio-engineered
loaded
with
specific
cargo).
So
far,
few
human
clinical
trials
have
been
conducted
questions
remain
unanswered
on
whether
heterogeneous
population
is
some
sub-populations,
how
best
we
can
scale-up
MSC-EV
production
isolation
utility,
what
format
they
should
administered.
as
reviewed
here,
there
now
supporting
use
medicine
research
establish
exploit
this
approach
societal
economic
benefit
warranted.